<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>9 Academy | Berthelsen Hall | Activity</title>
	<link>http://9.academy/members/petyellow3/activity/</link>
	<atom:link href="http://9.academy/members/petyellow3/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Berthelsen Hall.</description>
	<lastBuildDate>Tue, 03 Nov 2026 18:42:39 +0000</lastBuildDate>
	<generator>https://buddypress.org/?v=10.2.0</generator>
	<language>en-US</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">be3e02dbfa91f3957416b49a8ed81883</guid>
				<title>Berthelsen Hall posted an update: Evaluation regarding crucial genetic paths and also [&#133;]</title>
				<link>http://9.academy/activity/p/32081/</link>
				<pubDate>Wed, 07 Sep 2022 10:33:17 +0000</pubDate>

									<content:encoded><![CDATA[<p>Evaluation regarding crucial genetic paths and also appearance users can eventually generate a group of molecular guns to calculate the actual natural nature <a href="https://en.wikipedia.org/wiki/TENC1" rel="nofollow ugc">TENC1</a> associated with cancers also to Osimertinib solubility dmso identify brand-new specifications regarding molecular cancer certifying, category, along with prognostication. The attention&hellip;<span class="activity-read-more" id="activity-read-more-32081"><a href="http://9.academy/activity/p/32081/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">883955977f86481cee8cb787cafce2d7</guid>
				<title>Berthelsen Hall became a registered member</title>
				<link>http://9.academy/activity/p/32047/</link>
				<pubDate>Wed, 07 Sep 2022 10:24:11 +0000</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>